Walleye Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,079
Closed -$558K 4825
2023
Q4
$558K Buy
14,079
+5,749
+69% +$169K ﹤0.01% 2984
2023
Q3
$229K Sell
8,330
-208
-2% -$6.52K ﹤0.01% 3514
2023
Q2
$290K Buy
+8,538
New +$288K ﹤0.01% 3180
2023
Q1
Sell
-2,153
Closed -$96K 4892
2022
Q4
$96K Sell
2,153
-14,590
-87% -$521K ﹤0.01% 3997
2022
Q3
$471K Buy
16,743
+3,832
+30% +$117K ﹤0.01% 2965
2022
Q2
$348K Buy
12,911
+5,224
+68% +$152K ﹤0.01% 3274
2022
Q1
$262K Buy
+7,687
New +$246K ﹤0.01% 3556
2021
Q4
Sell
-3,518
Closed -$190K 5401
2021
Q3
$190K Buy
+3,518
New +$165K ﹤0.01% 3905
2020
Q3
Sell
-5,714
Closed -$74K 4162
2020
Q2
$74K Buy
+5,714
New +$25.3K ﹤0.01% 3656
2018
Q4
Sell
-3
Closed 4705
2018
Q3
$0 Buy
+3
New +$21 ﹤0.01% 5300
2017
Q3
Sell
-3
Closed 4150
2017
Q2
$0 Buy
+3
New +$133 ﹤0.01% 4534
2016
Q1
Sell
-5
Closed -$1K 5364
2015
Q4
$1K Buy
+5
New +$1.09K ﹤0.01% 5138

Other funds holding CLDX